Digital Smarter learning and better outcomes: How AI can provide an ... AI is revolutionising medical education, optimising learner outcomes and, ultimately, improving real-world patient care.
Views & Analysis Listening to the Patient Voice: Collaborate to meet unmet in... Pharma has a real willingness to listen to the patient voice – but how best can we turn that desire into action?
News FDA approves higher Wegovy dose via 4th priority voucher The US FDA has approved a fourth product via its new National Priority Voucher Programme -- a 7.2 mg dose of Novo Nordisk's weight loss drug Wegovy (semaglutide), to be marketed as Wegovy HD.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.